Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000543208 | SCV000652132 | pathogenic | Focal segmental glomerulosclerosis 5; Charcot-Marie-Tooth disease dominant intermediate E | 2022-12-06 | criteria provided, single submitter | clinical testing | This variant has been observed in individual(s) with Charcot-Marie-Tooth (CMT) and focal segmental glomerulosclerosis (PMID: 22187985; Invitae). In at least one individual the variant was observed to be de novo. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 472868). This variant is not present in population databases (gnomAD no frequency). This variant, c.490_498del, results in the deletion of 3 amino acid(s) of the INF2 protein (p.Ala164_Asp166del), but otherwise preserves the integrity of the reading frame. |
OMIM | RCV002286575 | SCV000045145 | pathogenic | Charcot-Marie-Tooth disease dominant intermediate E | 2011-12-22 | no assertion criteria provided | literature only |